Loading provider…
Loading provider…
Clinical Pathology/Laboratory Medicine Physician in Knoxville, TN
NPI: 1255381661HQ Phone
Get MD Mark's Phone Numberphone_androidMobile
Get MD Mark's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
AZ State Medical License
1991
NC State Medical License
1992 - 2026
FL State Medical License
1991 - 1994
MN State Medical License
1987 - 1992
IL State Medical License
1983 - 1987

American Board of Pathology
Anatomic Pathology & Clinical Pathology

American Board of Pathology
Blood Banking/Transfusion Medicine
Mayo Clinic Alix School of Medicine - Rochester
college.mayo.edu
Fellowship • Blood Banking/Transfusion Medicine
1987 - 1988
Pritzker School of Medicine
pritzker.uchicago.edu
Medical School
Until 1982
University of Chicago
Residency • Pathology-Anatomic and Clinical
1983 - 1987
Internship • Surgery
1982 - 1983
Emory University
BA • Chemistry
1974 - 1978
Visualizing the hemolytic transfusion reaction
Authors: Kathryn Elliott, Jack Sanders, Mark E. Brecher
Publication Date: 2003-03
An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies.
Authors: Scott Sailer
Publication Date: 2003-07
Plasma exchange: why we do what we do.
Authors: Mark E. Brecher
Publication Date: 2002-01
Lead Sponsor: Carelon Research
Collaborators: Genentech, Inc., National Heart, Lung, and Blood Institute (NHLBI)
Intervention / Treatment: DRUG: Rituximab, DRUG: Corticosteroids, PROCEDURE: Plasma exchange
Lead Sponsor: Carelon Research
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), Transfusion Medicine/Hemostasis Clinical Research Network
Intervention / Treatment: PROCEDURE: Higher Dose Prophylactic Platelet Transfusions, PROCEDURE: Medium Dose Prophylactic Platelet Transfusions, PROCEDURE: Lower Dose Prophylactic Platelet Transfusions